[Significance of the complement system for xenotransplantation: strategies for therapeutic intervention].
Hyperacute graft rejection triggered by the activation of the recipient's complement system represents the major obstacle to successful xenotransplantation. After the binding of preformed antibodies to vascular glycoproteins complement-induced activation and injury of endothelial cells with subsequent thrombosis leads to rapid destruction of foreign tissues. Inhibition of complement activation is therefore considered as a prerequisite for xenograft survival. Recent animal and cell culture experiments suggest that support of the physiological regulation of the complement system appears to be most promising. Besides the application of soluble complement inhibitors (e.g. soluble complement receptor 1, sCR1; C1 inhibitor) the genetic transfer of human membrane-bound complement regulatory proteins (e.g. DAF, CD59) offers new chances to protect the xenograft against the cytolytic complement attack. Results from the authors' experiments shall be included in a short overview to the issue.
Kirschfink
M
M
Institut für Immunologie, Universität Heidelberg. k92@ix.urz.uni-heidelberg.de
Haferkamp
A
A
Pomer
S
S
Chrupcala
M
M
Wosnik
A
A
Heckl-Ostreicher
B
B
D000818:Animals; D018957:CD59 Antigens / Q000235:genetics; D003167:Complement Activation / Q000187:drug effects / Q000235:genetics / Q000276:immunology*; D003169:Complement Inactivator Proteins / Q000235:genetics / Q000494:pharmacology*; D018014:Gene Transfer Techniques; D006084:Graft Rejection / Q000188:drug therapy / Q000235:genetics / Q000276:immunology*; D006085:Graft Survival / Q000187:drug effects / Q000235:genetics / Q000276:immunology; D006801:Humans; D014183:Transplantation, Heterologous / Q000276:immunology*
D018957:CD59 Antigens; D003169:Complement Inactivator Proteins